The definition of long COVID used in interventional studies
- PMID: 36964995
- DOI: 10.1111/eci.13989
The definition of long COVID used in interventional studies
Abstract
Introduction: There has been little consensus for a specific definition of long COVID, though several organizations have created varying ones. We sought to examine the definition of long COVID used in ongoing clinical trials.
Methods: We searched 'long COVID' and related terms on both PubMed and clinicaltrials.gov for randomized studies that either included patients with long COVID or had a persistent or long-term COVID-related outcome and abstracted long COVID definition components.
Results: Of the 92 studies, a laboratory-only confirmed diagnosis of COVID-19 was stipulated in 54.3% (n = 50) studies. We found eight different time durations specified for how long symptoms needed to have occurred, ranging from 4 to 52 weeks, with 12 weeks being the most common (34.8%; n = 32). 35.9% (n = 33) did not specify a time duration. There were 57 different symptoms specified in total, with a median of one symptom identified per study (range 0-32). 8.7% of trials adhered to NICE or WHO definitions.
Conclusion: Standardized definitions of long COVID should be applied in studies assessing this condition to unify and harmonize research on this topic.
Keywords: COVID long-haulers; long COVID; persistent COVID; randomized studies.
© 2023 Stichting European Society for Clinical Investigation Journal Foundation. Published by John Wiley & Sons Ltd.
References
REFERENCES
-
- Yong E. Long-haulers are fighting for their future. The Atlantic. Accessed September 6, 2022. https://www.theatlantic.com/science/archive/2021/09/covid-19-long-hauler...
-
- COVID-19 rapid guideline: managing the long-term effects of COVID-19. National Institute for Health and Care Excellence (NICE); 2020.
-
- World Health Organization. A clinical case definition of post COVID-19 condition by a Delphi consensus. Accessed September 5, 2022. https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_cond...
-
- Munblit D, O'Hara ME, Akrami A, Perego E, Olliaro P, Needham DM. Long COVID: aiming for a consensus. Lancet Respir Med. 2022;10(7):632-634. doi:10.1016/S2213-2600(22)00135-7
-
- Wisk LE, Nichol G, Elmore JG. Toward unbiased evaluation of Postacute sequelae of SARS-CoV-2 infection: challenges and solutions for the long haul ahead. Ann Intern Med. 2022;175(5):740-743. doi:10.7326/M21-4664